Modules
Brightwater Pathology Labs, LLC
Customer 41320
- Account Classification
- End-User Laboratory
- Classification Confidence
- High
- Sites
- HQ | 63bfff13d3bd886375d8177acdb25bc488b78a7a2f5bafc298458575fe3260e1
- Assigned Reps
- Priya Sandoval
- Website
- —
- Active Opportunity Count
- 2
- Published Count
- 2
- Revenue Base
- 18430.4
- Known GPBase
- 11171.2
- Analyzer Platforms
- Beckman Access / DxI
- Product Groups
- Beckman Access
- Recommended Contact
- Kyle Jarrett
- Backup Contact
- Wade Merriweather | | wade.merriweather@brightwaterpathologylabsllc.com
- Last Meaningful Activity
- 2026-08-05
- Customer Memory
- Verified transaction fact: platform/product group signal is Beckman Access / DxI. Verified item fact: storage requirement Fridge. AI inference: opportunity is based on deterministic order/quote pattern and requires normal rep validation during outreach. Verified item fact: storage requirement Fridge. AI inference: opportunity is based on deterministic order/quote pattern and requires normal rep validation during outreach.
- Evidence References
- Candidate CAND-03aaad00f1175f0aca50230fd5aa557119880d6d58144aec7e15186d150cf536 | Customer 41320 | Item 10920 | Candidate CAND-010c2f8a14a6e826286cbbf0530748fbd901f3d113c5d5e2984d0c2e0fe23622 | Customer 41320 | Quote 28132 | Item 4259
Opportunities (2)
| Source Sheet | Report Run ID | Candidate ID | Opportunity ID | Opportunity Series ID | Final Disposition | Assigned Rep | Territory Rep | Source Rep | Customer | Customer ID | Site | City | State | Region | Account Classification | Classification Confidence | Analyzer Platform | Product Group | SKU | Item Description | Quote Doc No | Order Doc No | Deterministic Signal | Revenue Low | Revenue Base | Revenue High | GP Low | GP Base | GP High | Priority Score | Confidence | Open Order | Open Quote | Suppression Status | Next Best Action | Evidence Reference |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Quote Leakage | 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-010c2f8a14a6e826286cbbf0530748fbd901f3d113c5d5e2984d0c2e0fe23622 | OPP-858126d571f4a09a0d79474a4c765ea2dfe399f5ac67f2088a1a7ea952fd76c9 | SER-4e46dbcd0b1e8bfd2df7d2923bec565b0636bf403d84b874d748f609a7c91d12 | Published | **** | — | **** | Brightwater Pathology Labs, LLC | 41320 | — | Kumasi | ASHANTI | — | End-User Laboratory | High | — | Beckman Access | 37200 | 37200 Beckman ACCESS PSA HYBRTECH RGT 100S | 28132 | — | High-Value Lost Quote Recovery on quote 28132; quote age 287 days; last modified 224 days ago; quoted value $63995.74; converted line value $0.00; unconverted line value $63995.74. | 6399.57 | 12799.15 | 19198.72 | 4307.32 | 8614.65 | 12921.97 | 71.95 | Medium | False | False | — | RESEND_QUOTE | Candidate CAND-010c2f8a14a6e826286cbbf0530748fbd901f3d113c5d5e2984d0c2e0fe23622 | Customer 41320 | Quote 28132 | Item 4259 |
| Cross-Sell | 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-03aaad00f1175f0aca50230fd5aa557119880d6d58144aec7e15186d150cf536 | OPP-1ff0a04337580e705a205e90e4647c92be89ddddbb70af048a95c6201c39ccbf | SER-d4695aeb5cf3036d0c5c119d28a652df5eabbc3c0a951b8aa10875a5c8821d8e | Published | **** | — | **** | Brightwater Pathology Labs, LLC | 41320 | HQ | Kumasi | ASHANTI | — | End-User Laboratory | High | Beckman Access / DxI | Beckman Access | B24838 | B24838 Access 25(OH) Vitamin D Reagent (for use on Access 2 Immunoassay Systems), 100 Determinations, 2 x 50 Tests - Lot 672030 | — | — | Verified by Description for Beckman Access / DxI; item purchased by 18 of 40 comparable active sites (45.0%); peer median annual revenue $5631.25. | 2815.63 | 5631.25 | 8446.88 | 1278.28 | 2556.55 | 3834.83 | 81.41 | High | False | False | — | CONFIRM_ANALYZER | Candidate CAND-03aaad00f1175f0aca50230fd5aa557119880d6d58144aec7e15186d150cf536 | Customer 41320 | Item 10920 |